These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 10981527)
1. Expression of and responses to CD2 and CD3 in 18-month-old children with and without atopic dermatitis. Jenmalm MC; Aniansson-Zdolsek H; Holt PG; Björkstén B Pediatr Allergy Immunol; 2000 Aug; 11(3):175-82. PubMed ID: 10981527 [TBL] [Abstract][Full Text] [Related]
2. Peripheral blood mononuclear cells from IgE- and non-IgE-associated allergic atopic eczema/dermatitis syndrome (AEDS) demonstrate increased capacity of generating interleukin-13 but differ in their potential of synthesizing interferon-gamma. Simon D; Borelli S; Braathen LR; Simon HU Allergy; 2002 May; 57(5):431-5. PubMed ID: 11972483 [TBL] [Abstract][Full Text] [Related]
3. PHA-induced IL-12R beta(2) mRNA expression in atopic and non-atopic children. Janefjord CK; Jenmalm MC Clin Exp Allergy; 2001 Oct; 31(10):1493-500. PubMed ID: 11678847 [TBL] [Abstract][Full Text] [Related]
4. [Antimycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis]. Kanda N Nihon Ishinkin Gakkai Zasshi; 2004; 45(3):137-42. PubMed ID: 15284827 [TBL] [Abstract][Full Text] [Related]
5. Enhanced production of IL4 but not of IFN gamma and IL 10 by peripheral blood mononuclear cells from atopic children in response to CD2 plus CD28 stimulation. Holter W; Emminger W; Majdic O; Knapp W Pediatr Allergy Immunol; 1996 May; 7(2):75-82. PubMed ID: 8902857 [TBL] [Abstract][Full Text] [Related]
6. T cell subsets and cytokines in allergic and non-allergic children. I. Analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Koning H; Neijens HJ; Baert MR; Oranje AP; Savelkoul HF Cytokine; 1997 Jun; 9(6):416-26. PubMed ID: 9199876 [TBL] [Abstract][Full Text] [Related]
7. The interleukin-13 production by peripheral blood T cells from atopic dermatitis patients does not require CD2 costimulation. Simon D; Von Gunten S; Borelli S; Braathen LR; Simon HU Int Arch Allergy Immunol; 2003 Oct; 132(2):148-55. PubMed ID: 14600427 [TBL] [Abstract][Full Text] [Related]
8. IL-4 and interferon-gamma production in children with atopic disease. Tang M; Kemp A; Varigos G Clin Exp Immunol; 1993 Apr; 92(1):120-4. PubMed ID: 8467557 [TBL] [Abstract][Full Text] [Related]
9. Pityrosporum ovale extracts increase interleukin-4, interleukin-10 and IgE synthesis in patients with atopic eczema. Kröger S; Neuber K; Gruseck E; Ring J; Abeck D Acta Derm Venereol; 1995 Sep; 75(5):357-60. PubMed ID: 8615051 [TBL] [Abstract][Full Text] [Related]
10. Different lymphocyte markers and cytokine expression in peripheral blood mononuclear cells in children with acute atopic dermatitis. Antúnez C; Torres MJ; Corzo JL; Pena RR; Mayorga C; Jurado A; Santamaría-Babi LF; Blanca M Allergol Immunopathol (Madr); 2004; 32(5):252-8. PubMed ID: 15456620 [TBL] [Abstract][Full Text] [Related]
11. Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis. Buchvald D; Lundeberg L Br J Dermatol; 2004 Mar; 150(3):484-92. PubMed ID: 15030331 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. Habu Y; Seki S; Takayama E; Ohkawa T; Koike Y; Ami K; Majima T; Hiraide H J Immunol; 2001 May; 166(9):5439-47. PubMed ID: 11313381 [TBL] [Abstract][Full Text] [Related]
13. In vitro responsiveness to IL-18 in combination with IL-12 or IL-2 by PBMC from patients with bronchial asthma and atopic dermatitis. El-Mezayen RE; Matsumoto T Clin Immunol; 2004 Apr; 111(1):61-8. PubMed ID: 15093553 [TBL] [Abstract][Full Text] [Related]
14. B7-2/CD28 costimulatory pathway in children with atopic dermatitis and its connection with immunoglobulin E, intracellular interleukin-4 and interferon-gamma production by T cells during a 1-month follow-up. Chernyshov PV J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):656-9. PubMed ID: 19250325 [TBL] [Abstract][Full Text] [Related]
15. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls. Imada M; Simons FE; Jay FT; Hayglass KT Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124 [TBL] [Abstract][Full Text] [Related]
16. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Till S; Durham S; Dickason R; Huston D; Bungre J; Walker S; Robinson D; Kay AB; Corrigan C Immunology; 1997 May; 91(1):53-7. PubMed ID: 9203965 [TBL] [Abstract][Full Text] [Related]
17. Development of the capacity of peripheral blood mononuclear cells to produce IL-4, IL-5 and IFN-gamma upon stimulation with house dust mite in children with atopic dermatitis. Kimura M; Yamaide A; Tsuruta S; Okafuji I; Yoshida T Int Arch Allergy Immunol; 2002 Mar; 127(3):191-7. PubMed ID: 11979044 [TBL] [Abstract][Full Text] [Related]
18. Increased cAMP and cAMP-dependent protein kinase activity mediate anti-CD2 induced suppression of anti-CD3-driven interleukin-2 production and CD25 expression. Lin J; Gettys TW; Qin L; Chavin KD; Yang Q; Ding Y; Punch JD; Bromberg JS Pathobiology; 1995; 63(4):175-87. PubMed ID: 8866788 [TBL] [Abstract][Full Text] [Related]
19. Antigen presenting cell-independent cytokine and spontaneous in vitro IgE production in patients with atopic dermatitis: increased interferon-gamma production and lack of effects of in vivo low-dose interferon-gamma treatment. Simon MR; Cooper KD; Norris RB; Blok B; King CL J Allergy Clin Immunol; 1995 Jul; 96(1):84-91. PubMed ID: 7622767 [TBL] [Abstract][Full Text] [Related]
20. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. Kanda N; Enomoto U; Watanabe S J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]